(2R,4S)-4-amino-2-methyl-5-(4-phenylphenyl)pentanoic acid
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

1039307-95-3(2R,4S)-4-amino-2-methyl-5-(4-phenylphenyl)pentanoic acid

● In Stock

Catalogue No.:VE009679
CAS No.:1039307-95-3
Mol. Formula:C18H21NO2
Mol. Weight:283.4 g/mol

Additional information on CAS 1039307-95-3

Parent drug

Sacubitril

IUPAC Name

(2R, 4S)-4-amino-2-methyl-5-(4-phenylphenyl)pentanoic acid

Synonyms

N/A

Smiles

CC(CC(CC1=CC=C(C=C1)C2=CC=CC=C2)N)C(=O)O

Description

It is one of impurity present in Sacubitril, Sacubitril is a neprilysin inhibitor, a neutral endopeptidase that cleaves natriuretic peptides such as an atrial natriuretic peptide, brain natriuretic peptide, and c-type natriuretic peptide, they are released under atrial and ventricle stress, which activate downstream receptors leading to vasodilation, natriuresis, and diuresis. endothelin-1 and peptide amyloid beta-protein. Inhibition of neprilysin reduced breakdown and increased concentration of endogenous natriuretic peptides in addition to increased levels of vasoconstricting hormones such as angiotensin II, which reduce the risk of cardiovascular death and heart failure.

References

Fala, L. (2015). Entresto (Sacubitril/Valsartan): First-in-Class Angiotensin Receptor Neprilysin Inhibitor FDA Approved for Patients with Heart Failure. American Health & Drug Benefits, 8(6), 330–334. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636283/

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url